Which term best describes an Investigational Product (IP) in a trial?

Which term best describes an Investigational Product (IP) in a trial?

• A. Drug, device, or biologic under investigation.
• B. An approved product used as standard care.
• C. A placebo only.
• D. A non-investigational product.

Answer: (D)

The term that fits best is the drug, device, or biologic that is being studied in the trial. An Investigational Product is the item under investigation to assess its safety and efficacy in humans, often because it has not yet been approved for the indication being tested. This can include a new drug, a novel formulation, or a new medical device being evaluated in the study. It’s not an approved product used as standard care, and it’s not a placebo, which serves as a control rather than the instrument of investigation. It also isn’t a non-investigational product, since by definition the IP is the product being investigated in the trial.

The term that fits best is the drug, device, or biologic that is being studied in the trial. An Investigational Product is the item under investigation to assess its safety and efficacy in humans, often because it has not yet been approved for the indication being tested. This can include a new drug, a novel formulation, or a new medical device being evaluated in the study. It’s not an approved product used as standard care, and it’s not a placebo, which serves as a control rather than the instrument of investigation. It also isn’t a non-investigational product, since by definition the IP is the product being investigated in the trial.